Profil
Antonio Costa is associated with Diant Pharma, Inc. as the Chief Executive Officer since 2019.
He is also the founder of Diant Pharma, Inc. which was founded in 2019.
Postes actifs de Antonio Costa
| Sociétés | Poste | Début |
|---|---|---|
Diant Pharma, Inc.
 Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019. | Directeur Général | 01/01/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Diant Pharma, Inc.
Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019. | Health Technology |
